These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1048 related items for PubMed ID: 14745863

  • 1. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK.
    Cancer; 2004 Feb 01; 100(3):479-89. PubMed ID: 14745863
    [Abstract] [Full Text] [Related]

  • 2. MRI screening in a clinic population with a family history of breast cancer.
    Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA.
    Ann Surg Oncol; 2008 Feb 01; 15(2):452-61. PubMed ID: 18026801
    [Abstract] [Full Text] [Related]

  • 3. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.
    Kurian AW, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1082-9. PubMed ID: 15894656
    [Abstract] [Full Text] [Related]

  • 4. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O'Loughlin M, Harms S, Bluemke DA, International Breast MRI Consortium Working Group.
    Cancer; 2005 May 01; 103(9):1898-905. PubMed ID: 15800894
    [Abstract] [Full Text] [Related]

  • 5. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.
    Cancer; 2003 Jan 01; 97(1):1-11. PubMed ID: 12491499
    [Abstract] [Full Text] [Related]

  • 6. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, Klijn JG, Dutch MRI Screening (MRISC) Study Group.
    Cancer; 2006 Jun 01; 106(11):2318-26. PubMed ID: 16615112
    [Abstract] [Full Text] [Related]

  • 7. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
    Warner E, Causer PA, Wong JW, Wright FC, Jong RA, Hill KA, Messner SJ, Yaffe MJ, Narod SA, Plewes DB.
    Breast J; 2011 Jun 01; 17(1):9-17. PubMed ID: 21251121
    [Abstract] [Full Text] [Related]

  • 8. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.
    Mitchell G, Antill YC, Murray W, Kirk J, Salisbury E, Lindeman GJ, Di Iulio J, Milner AD, Devereaux L, Phillips KA.
    Breast Cancer Res; 2005 Jun 01; 7(6):R1122-31. PubMed ID: 16457692
    [Abstract] [Full Text] [Related]

  • 9. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.
    Podo F, Sardanelli F, Canese R, D'Agnolo G, Natali PG, Crecco M, Grandinetti ML, Musumeci R, Trecate G, Bergonzi S, De Simone T, Costa C, Pasini B, Manuokian S, Spatti GB, Vergnaghi D, Morassut S, Boiocchi M, Dolcetti R, Viel A, De Giacomi C, Veronesi A, Coran F, Silingardi V, Turchett D, Cortesi L, De Santis M, Federico M, Romagnoli R, Ferrari S, Bevilacqua G, Bartolozzi C, Caligo MA, Cilotti A, Marini C, Cirillo S, Marra V, Martincich L, Contegiacomo A, Pensabene M, Capuano I, Burgazzi GB, Petrillo A, Bonomo L, Carriero A, Mariani-Costantini R, Battista P, Cama A, Palca G, Di Maggio C, D'Andrea E, Bazzocchi M, Francescutti GE, Zuiani C, Londero V, Zunnui I, Gustavino C, Centurioni MG, Iozzelli A, Panizza P, Del Maschio A.
    J Exp Clin Cancer Res; 2002 Sep 01; 21(3 Suppl):115-24. PubMed ID: 12585665
    [Abstract] [Full Text] [Related]

  • 10. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER, Park A, Borgen PI, Morris E, Montgomery LL.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1051-7. PubMed ID: 17206485
    [Abstract] [Full Text] [Related]

  • 11. Breast MRI: opportunities and challenges.
    Day D.
    Minn Med; 2009 Dec 01; 92(12):45-8. PubMed ID: 20092173
    [Abstract] [Full Text] [Related]

  • 12. Screening and follow-up of the patient at high risk for breast cancer.
    Willey SC, Cocilovo C.
    Obstet Gynecol; 2007 Dec 01; 110(6):1404-16. PubMed ID: 18055740
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of breast MRI in a patient with genetic risk.
    Cortesi L, Canossi B, De Santis M, Panizza P, Rossi G, Turchetti D, Del Maschio A, Ferrari S, Romagnoli R, Federico M, Silingardi V.
    J Exp Clin Cancer Res; 2002 Sep 01; 21(3 Suppl):131-6. PubMed ID: 12585667
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K, Emanuelsson M, Wiklund F, Gronberg H.
    Cancer; 2006 Mar 15; 106(6):1237-42. PubMed ID: 16475207
    [Abstract] [Full Text] [Related]

  • 18. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
    Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, Tombach B, Leutner C, Rieber-Brambs A, Nordhoff D, Heindel W, Reiser M, Schild HH.
    J Clin Oncol; 2010 Mar 20; 28(9):1450-7. PubMed ID: 20177029
    [Abstract] [Full Text] [Related]

  • 19. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A, Andersson I, Aspegren K, Linell F.
    Eur J Surg Oncol; 1991 Oct 20; 17(5):466-76. PubMed ID: 1657650
    [Abstract] [Full Text] [Related]

  • 20. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May 20; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.